Literature DB >> 23337276

Versatility of Ilizarov technique in difficult cases of ankle arthrodesis and review of literature.

Ashraf A Khanfour1.   

Abstract

BACKGROUND: Ankle arthrodesis is a well-established procedure that has been successfully used for treatment of end stage arthritis of the ankle for well over a century. Internal fixation for ankle arthrodesis is adequate in most of the cases. However, surgeons and patients are occasionally confronted with cases in need for ankle arthrodesis but do not lend itself well to the ideal position and/or internal fixation. These cases may even contraindicate internal fixation. The aim of this study is to assess the results of ankle arthrodesis using different modalities of Ilizarov techniques and demonstrating its high versatility in treating such difficult cases. PATIENTS AND METHODS: This is a prospective study. Thirty cases of ankle fusion for end stage arthritis or instability were performed in the period between January 2002 and December 2007 at the Health Insurance Reference Hospitals, Alexandria, Egypt. Tibiotalar fusion was done in 22 cases and tibiocalcaneal fusion in 8 cases using different modalities of Ilizarov technique. The mean follow up period was 5.5 years (range 4-8, SD 1.9).
RESULTS: Sound and painless fusion was achieved in all the cases except one (97%). The difference between the mean preoperative and postoperative American Orthopaedic Foot and Ankle Society (AOFAS) was found to be statistically highly significant (t=10.1, p=0.001). Many minor complications were encountered during the course of treatment in the form of: pin tract infections, wound dehiscence, cellulitis that was managed effectively with local wound care, oral antibiotics.
CONCLUSION: The versatility of the combinations of assemblies afforded by Ilizarov fixator was found to be endless. This makes the Ilizarov fixator to be an effective and versatile mean of treating difficult cases of ankle arthrodesis.
Copyright © 2012 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23337276     DOI: 10.1016/j.fas.2012.10.001

Source DB:  PubMed          Journal:  Foot Ankle Surg        ISSN: 1268-7731            Impact factor:   2.705


  7 in total

1.  Recombinant human BMP-2 increases the incidence and rate of healing in complex ankle arthrodesis.

Authors:  Mitchell S Fourman; Eugene W Borst; Eric Bogner; S Robert Rozbruch; Austin T Fragomen
Journal:  Clin Orthop Relat Res       Date:  2013-08-29       Impact factor: 4.176

2.  A New Classification for Ankle Arthrodesis When Using an External Fixator.

Authors:  Hidenori Matsubara; Koji Watanabe; Munetomo Takata; Issei Nomura; Hiroyuki Tsuchiya
Journal:  Strategies Trauma Limb Reconstr       Date:  2019 Sep-Dec

3.  Tibiocalcaneal arthrodesis using the Ilizarov fixator in compromised hosts: an analysis of 19 patients.

Authors:  Charlotte Reinke; Sebastian Lotzien; Emre Yilmaz; Yannik Hanusrichter; Christopher Ull; Hinnerk Baecker; Thomas A Schildhauer; Jan Geßmann
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-23       Impact factor: 2.928

Review 4.  An engineering review of external fixators.

Authors:  P L N Fernando; Aravinda Abeygunawardane; Pci Wijesinghe; Parakrama Dharmaratne; Pujitha Silva
Journal:  Med Eng Phys       Date:  2021-11-04       Impact factor: 2.242

Review 5.  Diagnostic Criteria and Treatment of Acute and Chronic Periprosthetic Joint Infection of Total Ankle Arthroplasty.

Authors:  Kempland C Walley; Christopher B Arena; Paul J Juliano; Michael C Aynardi
Journal:  Foot Ankle Orthop       Date:  2019-04-30

6.  Management of Elderly Traumatic Ankle Arthritis with Ilizarov External Fixation.

Authors:  Jun Li; Wenzhao Wang; Hai Yang; Bohua Li; Lei Liu
Journal:  Orthop Surg       Date:  2022-08-24       Impact factor: 2.279

7.  Clinical evaluation of arthrodesis with Ilizarov external fixator for the treatment of end-stage ankle osteoarthritis: A retrospective study.

Authors:  Nan Ma; Zhi Li; Delei Li; Yehua Hu; Ning Sun
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.